{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:07:05Z","timestamp":1784074025359,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.trim.2024.102119","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:38:06Z","timestamp":1725323886000},"page":"102119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases"],"prefix":"10.1016","volume":"87","author":[{"given":"Jingyu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.trim.2024.102119_bb0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"You","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.trim.2024.102119_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.trim.2024.102119_bb0015","article-title":"Chidamide as maintenance after chemotherapy or hematopoietic stem cell transplantation in 27 children with T-cell lymphoblastic leukemia: a real-world prospective study","volume":"10","author":"Li","year":"2023","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.trim.2024.102119_bb0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41409-023-02045-w","article-title":"Chidamide maintenance therapy in high-risk T-ALL\/T-LBL after allo-HSCT: a prospective, single-center, single-arm study","volume":"58","author":"Guo","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2024.102119_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/hon.2980","article-title":"Prognostic factors of children and adolescents with T-cell acute lymphoblastic leukemia after allogeneic transplantation","volume":"40","author":"Ishida","year":"2022","journal-title":"Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.trim.2024.102119_bb0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hon.2841","article-title":"Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T-cell precursor acute lymphoblastic leukemia","volume":"39","author":"Meng","year":"2021","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.trim.2024.102119_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10428194.2019.1660966","article-title":"SET-CAN fusion gene as poor prognosis predictor in adult T-cell acute lymphoblastic leukemia","volume":"61","author":"Yang","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.trim.2024.102119_bb0040","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/MCB.25.2.728-739.2005","article-title":"Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo","volume":"25","author":"Daelemans","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.trim.2024.102119_bb0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jcp.21199","article-title":"Impairment of erythroid and megakaryocytic differentiation by a leukemia-associated and t(9;9)-derived fusion gene product, SET\/TAF-Ibeta-CAN\/Nup214","volume":"214","author":"Saito","year":"2008","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.trim.2024.102119_bb0050","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia","volume":"111","author":"Van Vlierberghe","year":"2008","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.trim.2024.102119_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029294","article-title":"The characteristics and prognostic significance of the SET-CAN\/NUP214 fusion gene in hematological malignancies: a systematic review","volume":"101","author":"Wang","year":"2022","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.trim.2024.102119_bb0060","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1182\/blood-2013-08-521518","article-title":"SET-NUP214 is a recurrent gammadelta lineage-specific fusion transcript associated with corticosteroid\/chemotherapy resistance in adult T-ALL","volume":"123","author":"Ben Abdelali","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.trim.2024.102119_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3807","article-title":"Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine","volume":"31","author":"Suresh","year":"2017","journal-title":"Biomed. Chromatogr."},{"issue":"8","key":"10.1016\/j.trim.2024.102119_bb0070","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/annonc\/mdv237","article-title":"Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma","volume":"26","author":"Shi","year":"2015","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.trim.2024.102119_bb0075","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00280-011-1766-x","article-title":"Chidamide (CS055\/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity","volume":"69","author":"Ning","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.trim.2024.102119_bb0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biocel.2018.03.004","article-title":"HDAC inhibitors as epigenetic regulators for cancer immunotherapy","volume":"98","author":"Conte","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.trim.2024.102119_bb0085","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/10428194.2016.1247956","article-title":"Targeting histone deacetylases in T-cell lymphoma","volume":"58","author":"Moskowitz","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.trim.2024.102119_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-017-0377-8","article-title":"Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells","volume":"9","author":"Li","year":"2017","journal-title":"Clin. Epigenetics"},{"issue":"13","key":"10.1016\/j.trim.2024.102119_bb0095","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2217\/pgs-2017-0061","article-title":"Low-dose decitabine enhances chidamide-induced apoptosis in adult acute lymphoblast leukemia, especially for p16-deleted patients through DNA damage","volume":"18","author":"Shi","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.trim.2024.102119_bb0100","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/cam4.2097","article-title":"Circulating PD-1 (+) cells may participate in immune evasion in peripheral T-cell lymphoma and chidamide enhance antitumor activity of PD-1 (+) cells","volume":"8","author":"Zhang","year":"2019","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.trim.2024.102119_bb0105","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/10428194.2019.1691195","article-title":"Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma\/leukemia","volume":"61","author":"Guan","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.trim.2024.102119_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International consensus classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.trim.2024.102119_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-011-1289-x","article-title":"Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement","volume":"91","author":"Chae","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.trim.2024.102119_bb0120","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.2147\/OTT.S258365","article-title":"SET-CAN Fusion Gene in Acute Leukemia and Myeloid Neoplasms: Report of Three Cases and a Literature Review","volume":"13","author":"Zhang","year":"2020","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.trim.2024.102119_bb0125","article-title":"Determining the appropriate treatment for T-cell acute lymphoblastic leukemia with SET-CAN\/NUP214 fusion: perspectives from a case report and literature review","volume":"11","author":"Lin","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.trim.2024.102119_bb0130","first-page":"1047","article-title":"Expression of SET-NUP214 fusion gene in patients with T-cell acute lymphoblastic leukemia and its clinical significance","volume":"20","author":"Dai","year":"2012","journal-title":"J. Exp. Hematol."},{"issue":"10","key":"10.1016\/j.trim.2024.102119_bb0135","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2011-12-399287","article-title":"Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation","volume":"120","author":"G\u00f6kbuget","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.trim.2024.102119_bb0140","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.12998\/wjcc.v8.i14.3122","article-title":"Effect of chidamide on treating hepatosplenic T-cell lymphoma: a case report","volume":"8","author":"Wang","year":"2020","journal-title":"World J. Clin. Cases"},{"issue":"1","key":"10.1016\/j.trim.2024.102119_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-017-0439-6","article-title":"Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China","volume":"10","author":"Shi","year":"2017","journal-title":"J. Hematol. Oncol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T03:53:52Z","timestamp":1732593232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327424001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S0966327424001357"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2024.102119","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2024.102119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102119"}}